Y
Yahoo! News
Guest
Japan's biggest drugs maker Takeda Pharmaceutical said Tuesday it would fight a huge $6.0 billion damages order imposed by a US jury following a trial over the safety of its Actos diabetes medicine. The company said it "respectfully disagrees" with the judgement awarded in the southern state of Louisiana on Monday, which also ordered the firm's co-defendant, US drugs firm Eli Lilly, to pay $3.0 billion in damages. The issue at the trial, which began in February, was whether the drug could be blamed for bladder cancer in a plaintiff who was taking the medicine, and whether the firm knew about those risks. "We believe the evidence did not support a finding that Actos caused (the plaintiff's) bladder cancer.
Continue reading...
Continue reading...
